AAREY DRUGS & PHARMACEUTICALS
Back to All Ratios
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 16.07 | 19.64 | 11.24 | 12.30 | 7.30 |
What is the latest Price to Cash Earnings (PCE) ratio of AAREY DRUGS & PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 16.07 |
| Mar2024 | 19.64 |
| Mar2023 | 11.24 |
| Mar2022 | 12.30 |
| Mar2021 | 7.30 |
How is Price to Cash Earnings (PCE) of AAREY DRUGS & PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 16.07 | -18.18 | |
| Mar2024 | 19.64 | 74.73 | |
| Mar2023 | 11.24 | -8.62 | |
| Mar2022 | 12.3 | 68.49 | |
| Mar2021 | 7.3 | - | |
Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of AAREY DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AAREY DRUGS & PHARMACEUTICALS | ₹229.1 Cr | 21.2% | 17.2% | 88.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AAREY DRUGS & PHARMACEUTICALS | 21.2% |
17.2% |
88.5% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses